Pro-Dex Valuation Multiples

Discover Pro-Dex's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Onward Medical, Edap TMS, Ilex Medical, Neuronetics and more.

Pro-Dex Overview

About Pro-Dex

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.


Founded

1994

HQ

United States

Employees

181

Financials (LTM)

Revenue: $77M
EBITDA: $14M

EV

$207M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Pro-Dex Financials

Pro-Dex reported last 12-month revenue of $77M and EBITDA of $14M.

In the same LTM period, Pro-Dex generated $24M in gross profit, $14M in EBITDA, and $12M in net income.

Revenue (LTM)


Pro-Dex P&L

In the most recent fiscal year, Pro-Dex reported revenue of $78M and EBITDA of $14M.

Pro-Dex is profitable as of last fiscal year, with gross margin of 31%, EBITDA margin of 18%, and net margin of 18%.

See analyst estimates for Pro-Dex
LTMLast FY202320242025202620272028
Revenue$77M$78M$50M$60M$72M
Gross Profit$24M$24M$14M$17M$21M
Gross Margin31%31%27%28%30%
EBITDA$14M$14M$8M$9M$14M
EBITDA Margin19%18%15%15%20%
EBIT Margin16%17%13%15%16%
Net Profit$12M$14M$5M$6M$11M
Net Margin16%18%9%9%16%
Net Debt-$10M---

Financial data powered by Morningstar, Inc.

Pro-Dex Stock Performance

Pro-Dex has current market cap of $198M, and enterprise value of $207M.

Market Cap Evolution


Pro-Dex's stock price is $61.87.

Pro-Dex share price decreased by 0.4% in the last 30 days, and increased by 82.8% in the last year.

Pro-Dex has an EPS (earnings per share) of $4.28.

See more trading valuation data for Pro-Dex
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$207M$198M-1.1%-0.4%5.7%82.8%$4.28

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Pro-Dex Valuation Multiples

Pro-Dex trades at 2.7x EV/Revenue multiple, and 14.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Pro-Dex

EV / Revenue (LTM)


Pro-Dex Financial Valuation Multiples

As of September 5, 2026, Pro-Dex has market cap of $198M and EV of $207M.

Pro-Dex has a P/E ratio of 15.9x.

LTMLast FY202320242025202620272028
EV/Revenue2.7x2.7x4.1x3.4x2.9x
EV/EBITDA14.5x14.5x27.3x22.4x14.6x
EV/EBIT16.6x15.9x32.0x23.2x17.9x
EV/Gross Profit8.7x8.5x15.2x12.2x9.7x
P/E15.9x14.5x42.9x35.6x17.5x
EV/FCF-30.6x42.7x181.1x(70.7x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Pro-Dex Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Pro-Dex Margins & Growth Rates

Pro-Dex grew revenue by 4% and EBITDA by 0% in the last fiscal year.

In the most recent fiscal year, Pro-Dex reported gross margin of 31%, EBITDA margin of 18%, and net margin of 18%.

See estimated margins and future growth rates for Pro-Dex

Pro-Dex Margins

Last FY202420252026202720282029
Gross Margin31%28%30%32%
EBITDA Margin18%15%20%18%
EBIT Margin17%15%16%16%
Net Margin18%9%16%15%
FCF Margin9%2%(4%)-

Pro-Dex Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%21%20%10%
Gross Profit Growth6%25%26%17%
EBITDA Growth0%22%53%1%
EBIT Growth(2%)38%29%11%
Net Profit Growth(30%)21%104%3%
FCF Growth-(76%)(356%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Pro-Dex Operational KPIs

Pro-Dex's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Pro-Dex's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Pro-Dex's Rule of X is 43% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Pro-Dex
LTMLast FY202320242025202620272028
Rule of 4023%28%---
Bessemer Rule of X31%43%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue1%1%0%0%0%
G&A Expenses to Revenue9%10%8%7%8%
R&D Expenses to Revenue5%4%6%6%5%
Opex to Revenue-15%14%13%12%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Pro-Dex Competitors

Pro-Dex competitors include Onward Medical, Edap TMS, Ilex Medical, Neuronetics, AOTI, Lucid Diagnostics, Medinice, Deltex Medical Group, Huons Co and Ascom.

Most Pro-Dex public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Onward Medical30.8x11.4x(3.0x)(2.4x)
Edap TMS3.0x3.6x(8.5x)(7.9x)
Ilex Medical0.4x-3.4x-
Neuronetics1.9x1.8x(9.9x)(19.7x)
AOTI2.9x2.7x25.2x27.0x
Lucid Diagnostics36.8x29.9x(3.0x)(3.4x)
Medinice-5.9x(103.5x)6.8x
Deltex Medical Group----

This data is available for Pro users. Sign up to see all Pro-Dex competitors and their valuation data.

Start Free Trial

Acquisitions by Pro-Dex

Pro-Dex has acquired 1 company to date.

Last acquisition by Pro-Dex was on February 12th 2026. Pro-Dex acquired Advanced Precision Machining for $9M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Pro-Dex

Advanced Precision Machining
Description
Advanced Precision Machining produces custom precision components through machining and fabrication processes. The company caters to aerospace, defense, and medical sectors with high-tolerance parts from its US facilities.
HQ CountryUnited States
HQ City
-
Deal Date12 Feb 2026
Valuation$9M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Pro-Dex acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Pro-Dex

Who are competitors of Pro-Dex?Pro-Dex main competitors include Onward Medical, Edap TMS, Ilex Medical, Neuronetics, AOTI, Lucid Diagnostics, Medinice, Deltex Medical Group, Huons Co, Ascom.

See public comps similar to Pro-Dex

Lists including Pro-Dex

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial